Abstract: Anesthesia process is to maintain a triad of hypnosis, analgesia and neuromuscular blockade by infusing several drugs which are specific for each state. This work focuses on controlling the hypnosis with RTDA (Robustness, Set-point tracking, Disturbance rejection, Aggressiveness) controller by regulation of propofol using Bispectral Index (BIS) as primary controlled variable. One of the main advantages of RTDA controller is its intuitive tuning parameters when compared to PID and MPC controllers. For the controller design, a fourthorder nonlinear pharmacokinetic -pharmacodynamic representation is used for the hypnosis dynamics of patients. Nominal values for pharmacokinetics and pharmacodynamics were taken from the literature. Then the performance of the RTDA controller is compared with the performances of the PID and MPC controllers. Robust performance of these controllers is tested for a selected range of patients by considering variability in parameters of the patient model. Also studied are the relative performances with respect to different set-points in BIS, and disturbances in BIS signal. Numerical simulations show that the RTDA controller provides better performance compared to the other two controllers.
INTRODUCTION
During surgical process, anesthesiologists infuse several drugs by adjusting infusion devices to maintain an adequate level of anesthetic depth (a triad combination of hypnosis, analgesia and muscle relaxation). Measurement and control of hypnosis during surgery is one of the important problems in biomedical field (Bibian et al. [2005] ). Hypnosis is related to unconsciousness and also to the inability of the patient to recall events (amnesia). An automatic controller that infuses drugs based on patient's anesthetic level provides more benefits, such as: (i) reduction of anesthetist's workload during the surgery and letting him/her to monitor and deal with other critical aspects of the surgery, (ii) more frequent sampling of the controlled variable results in frequent adjustment of the drug delivery rate and leads to better performance when compared to manual administration, (iii) the drug dosage is tailored to the patients' requirements and response characteristics leading to minimal drug consumption, intraoperative awareness and recovery times, decrease in the cost of surgery and postoperative care, and (iv) both overdosage and under-dosage of the drugs are avoided. Overall, this improves the patient's rehabilitation and safety during and after the surgery (Bailey et al. [2005] ).
However, in order to design a feedback controller for controlling hypnosis, a reliable mathematical model of the ⋆ This work was supported by the National University of Singapore, Singapore in the form of a research scholarship to the first author.
patient to represent hypnosis and also appropriate hardware devices to measure and monitor the level of hypnosis are required. In general, mammillary compartmental models are widely used to describe the pharmacokinetics (PK) and pharmacodynamics (PD) of inhalationally and intravenously administered drugs (Bibian et al. [2005] ). The mathematical model employed in recent studies on hypnosis control is a series combination of a linear PK model and a nonlinear PD model. A theoretical effect compartment is also attached to the central compartment to represent the time-lag in the patient response to anesthesia. The values for parameters used in the PK and PD models are the population mean values and so the "patients" would have parameters that are different from the nominal values used in the controller design. Hence, the designed controller should be robust and result in stable responses for all the patients (Grieder et al. [2001] ). A commercial monitor (approved by U.S. Food and Drug Administration (FDA)) from Aspect Medical systems (Newton, MA, USA), is available to measure the depth of hypnosis in terms of Bispectral Index (BIS). BIS is an Electroencephalogram (EEG) derived variable that quantifies the power and phase couplings of the EEG at different frequencies (Rampil [1998] ).
Propofol is a common intravenous anesthetic drug that is widely used for both induction and maintenance of general anesthesia during surgical operations. Its favorable pharmacokinetic profile and inhibition of postoperative nausea and vomiting makes it a popular anesthetic drug. Many closed-loop feedback systems for anesthesia control based on propofol infusion have been proposed in the literature. These works employ various surrogate measurements such as EEG as the measured variables (Struys et al. [2006] ). Although the proposed closed-loop systems work well in clinical anesthesia, Struys et al. [2004] proposed a simulation methodology to test the performance of the two published controllers (Proportional-Integral-Derivative (PID) and model based controllers) under extreme conditions (sudden increase in BIS). They claimed that model based controller outperformed the conventional PID controller.
The contribution of this article is to demonstrate the application of a recently proposed regulatory controller, namely RTDA (Robustness, Set-point tracking, Disturbance rejection, Aggressiveness) controller for control of hypnosis. The RTDA controller (Ogunnaike et al. [2006] ) is developed for SISO (single-input, single-output) processes and combines the simplicity of PID controller with the advantages of Model Predictive Controller (MPC). The RTDA controller is designed here to control hypnosis using BIS as the controlled variable by manipulating propofol infusion rate. We also compare the performance of RTDA controller with that of MPC (Morari et al. [1999] , Furutani et al. [2005] ) and PID controller. Acknowledging the presence of inevitable patient-model mismatch, simulations were conducted to check the robustness of all these controllers. The three controller schemes were also tested for set-point change, and disturbance rejection. These simulations show that RTDA and MPC controllers perform better than the PID controller; furthermore, RTDA controller shows relatively best performance.
MATHEMATICAL MODEL FOR BIS RESPONSE
The model developed for BIS response to propofol infusion consists of two interacting parts: a PK model for estimating the distribution of propofol in the internal organs, and a PD model to describe the effect of propofol on the measured physiological variable, i.e., BIS. Figure 1 depicts a schematic of the system -comprising of propofol delivery circuit, the PK and PD models. For the distribution of propofol, a mammillary three compartmental PK model is adopted from literature (Marsh et al. [1991] ). The model was assumed to be linear with three compartments and elimination from the central compartment, V 1 . In this compartment (plasma compartment), the drug dissolves and is carried to the other two compartments. The second compartment is a shallow peripheral compartment, V 2 , which is characterized by a very rapid movement of the drug from the plasma to this compartment. This is the characteristic of certain tissues which are well perfused (vessel-rich group). The third compartment is a deep peripheral compartment, V 3 , which is characterized by a slow distribution of the drug from the central compartment to this compartment. This is because of the equilibration of the blood with tissues which are less well perfused.
Initially, the PK part assumes that all compartments ( Figure 1 ) have a zero concentration of the drug (propofol). To achieve rapid target plasma drug concentration, (i.e., concentration in V 1 ), sufficient drug must be given as a bolus dose. If the plasma drug concentration is to be kept constant, the amount of drug entering it and leaving it must be equal. Drug leaves the blood to pass into V 2 and V 3 at a gradually decreasing rate as the concentrations in these compartments increase. Drug also leaves the blood because it is metabolized (mainly in the liver). The PD part assumes some time delay between the infusion of propofol in the bloodstream and the dissolving of propofol in brain tissue thereby affecting the hypnosis level. This effect on hypnosis level is represented by a nonlinear equation relating the state variables and other system variables to BIS. Figure 1 shows the PK model for distribution of drug and is described by a mass balance between the two compartments which are attached to the central compartment. The main assumptions here are that the central compartment is a well mixed tank with the plasma propofol concentration being uniform everywhere and the distribution of propofol is not affected by the presence of other drugs. Hence, the resulting mass balance for propofol in the central compartment is given by (1).
Pharmacokinetic model of Propofol
where C 1 , C 2 ,a n dC 3 are concentrations of propofol (µg/ml) in the first (central), second and third compartments respectively; V 1 , V 2 ,a n dV 3 a r et h er e s p e c t i v ev o lumes (ℓ); k 12 , k 13 , k 21 ,a n dk 31 are the mammillary rate constants (min −1 ) of the respective compartments, k 10 is the hepatic metabolism rate constant to represent the elimination rate of propofol from the patient (min −1 ); ρ =1 0( mg/ml) is the available propofol concentration;k =6 0( min/hr) is a normalization constant; and U is the infusion rate of propofol (ml/hr). To convert U in ml/hr to u in mg/kg/hr (normalized propofol infusion rate with respect to patient weight), it is multiplied by ρ/w,wherew is the weight of the patient in kg. Similarly for the second and third compartments, the corresponding mass balance is
With the availability of different sets of PK parameters reported by various research groups, it is difficult to select a specific PK parameter set from all the available sets. Usually with all the PK sets, there is a difference 17th IFAC World Congress (IFAC'08) Seoul, Korea, July 6-11, 2008 between predicted and actual concentrations. This is not so important provided the actual concentrations are within the desired therapeutic window. The usefulness of targetcontrolled infusion lies in the ability to dose more accurately, to maintain stable drug concentrations (and therefore stable effects) and to make proportional changes to the concentrations. Coetzee et al. [1995] worked with several PK parameter sets and concluded that the parameters provided by Marsh et al. [1991] are the most accurate ones.
Values of these parameters in (1) and (2) for the Marsh model are summarized in Table 1 . Table 1 . Parameters of the PK model for 34 year old and 66 kg subject (Marsh et al. [1991] )
191.1
Pharmacodynamic model of Propofol
The above PK model is limited to the representation of distribution kinetics of propofol into different compartments. A PD model is required to measure the effect of drug on the anesthetic level. The PD model consists of an effect-site compartment model which represents the time-lag between the distribution of drug and its effect on BIS which is given by the nonlinear Hill equation. The effect-site compartment accounts for the equilibration time between plasma drug concentration and central nervous system (brain) concentration. The effect-site concentration, C e and plasma drug concentration, C 1 are related by a first-order lag given by
where k e0 is the time course of equilibration between the plasma and the effect-site. The effect-site concentration is related to BIS as (Hill equation):
where,
and EC 50 is the concentration of drug at half maximal effect and represents the patient's sensitivity to the drug, and γ is a dimensionless parameter that determines the degree of nonlinearity. BIS has the range 0 to 100, where BIS 0 = 100 denotes a fully conscious state and BIS MAX = 0 denotes nil cerebral electrical activity, i.e., deep coma. With this information, (4) can be written as:
The parameters k e0 = 0.349 min −1 , EC 50 =2 . 6 5 µg/ml and γ = 2.561 were the nominal values obtained from the pooled analysis (Schnider et al. [1999] ).
CONTROLLER DESIGN
RTDA controller uses a First-Order Plus Time-Delay (FOPTD) approximation of the process -essentially the same information used to design and tune a PID controller. The main advantage of the RTDA controller is that it has independent parameters θ R , θ T , θ D and θ A that permits the user to directly and independently alter the robustness, set-point tracking, disturbance rejection and aggressiveness of the controller. Furthermore, these tuning parameters are normalized to lie between 0 and 1 (Mukati et al. [2004] ). The main features and the governing equations of the RTDA controller as described in (Mukati et al. [2004] ) are given below for the benefit of the readers.
The FOPTD model can be written as:
where y, u, K, α,a n dτ respectively represents process output, input, gain, time delay, and time constant. Since RTDA controller is designed in digital form, the discretised form of (6) is given by:
.. (7) where, a = e −∆t
; m = round α ∆t and ∆t is the sampling time.
In the derivation of the control law, it is assumed that at each time instant k, the current control move u(k)i s held constant over the prediction horizon N beyond the delay period, m.T h ec o n t r o lm o v eu(k)i sc h o s e ns oa st o bring the predicted process output as close as possible to the reference trajectory. Basedo nt h i ss t r a t e g y ,p r e d i c t e d process output is given by:
The use of a FOPTD model in place of the true model, results in modeling error between the actual process output and the model predicted output, e (k)=y (k) −ŷ (k). The modeling error, e(k) can be grouped into two types of estimates e m (k)a n de D (k)a sg i v e nb y :
where e m (k) represents the inherent modeling uncertainties and e D (k) represents the effects of unmeasured disturbances. By using Bayesian estimation procedure, e D (k) can be estimated as:
where θ R (0 <θ R < 1) serves as the tuning parameter for robustness of the controller. With the current error estimate, the future error is then estimated to update the model prediction. This can be written as:
for m +1≤ j ≤ m + N ,w h e r e ,
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For the purpose of set-point (y d ) tracking, a desired setpoint trajectory (y * ) needs to be defined. The control action is computed based on at each instant k, the single control move, u(k), is determined to minimize the error between predicted output from the desired set-point trajectory, y * , over the next N discrete steps in the future. The desired set-point trajectory for the set-point, y d ,i s given by: (14) with θ T (0 <θ T < 1) serves as the tuning parameter for set-point tracking.
The tuning parameter for overall controller aggressiveness, θ A , depends on the value of N and which is given by:
Having defined a reference trajectory and derived the model prediction with error correction, the current optimal control action u(k) may be obtained analytically as:
where
RESULTS AND DISCUSSION
This section provides a comparison between the performances of RTDA, MPC and PID controllers. Because, FOPTD model is used to design and tune RTDA and PID controllers, the four state, nonlinear patient model is approximated to FOPTD model through process reaction curve method. Figure 2 depicts the degree of approximation obtained. The four parameters of this controller are tuned for the best performance i.e., minimum Integral of the Absolute Error (IAE) value (Seborg et al. [2004] ) based on set-point changes to BIS from 100 to 50 (the BIS value recommended during surgery). Figure 3 depicts the performance of the RTDA controller for different values of θ T and based on the performance, a value of 0.044 is selected. These settings (θ R = 0.037, θ D = 0.937, θ A = 0.812, and θ T = 0.044) will be used for further performance comparisons. The sampling time of all the controllers is set to 0.0833 min which is equal to the sampling time of BIS. 
Performance comparison for a step change in BIS during surgery
The anesthesiologist can anticipate periods that involve high surgical stimulation (requires higher sedation) and periods during which light sedation is sufficient during the surgery. For example, if surgical stimulation is severe at any time during the surgical process, the patient needs to be more unconscious and hence the BIS value should be decreased to some lower value (e.g. 40). Afterwards, towards the end of the surgery, the patient needs to be less unconscious and the BIS set-point may be increased from 40 to 60. The three controllers are now tested for different step changes in BIS value on the nominal patient. Figure 4 depicts the performance of the three controllers for a step change in BIS from 50 to 40 at t =5 0min and from 40 to 60 at t = 100 min. Better transition of the BIS is obtained with RTDA and MPC controllers when compared to PID 17th IFAC World Congress (IFAC'08) Seoul, Korea, July 6-11, 2008 controller. Also, the PID controller has a relatively longer settling time. 
Robustness comparison
This section discusses the robustness of the three controllers based on the IAE values. We would like to test if all of these three controllers can meet the performance specifications (BIS between 40 to 60) despite significant and reasonable variation in the model parameters (interand intra-patient variability). Here, we assume that variability is in both the PK and PD model parameters. There is a variation of 25 % in PK model parameters (Schnider et al. [1998] ) and the possible range of PD parameters has been assumed (Schnider et al. [1999] ). After a sensitivity test of the parameters, 17 patients (representing the population of patients) are selected and used for comparing the robustness of the three controllers. Figure 5 depicts the closed-loop performance of the RTDA controller with 17 patient sets. The top subplot shows the tracking performance with respect to BIS set-point 50. With all these sets, the BIS value reached the setpoint with some undershoot and time delay based on the patient's sensitivity to the drug. Insensitive patient (IAE = 324) has sluggish response whereas sensitive patient (IAE = 141) has faster response when compared to the response of the nominal patient (IAE = 217). The bottom subplot of Figure 5 represents the propofol infusion rate, u.I n line with the above observations, more drug is injected to the insensitive patient and less drug is infused into the sensitive patient as compared to the nominal patient. is lower for the RTDA controller (IAE = 226) and highest for the PID controller (IAE = 250). The IAE value for the MPC controller is 237 -this is slightly higher than that obtained for the RTDA controller.
Performance comparison for a sudden disturbance in BIS signal
Faults can occur with any of the equipment or variables during surgery. BIS signal may be corrupted by artifacts such as measurement noise or a disturbance in BIS signal which causes arousal reflex. For better control performance, noise and disturbance in the BIS signal must be handled appropriately (e.g. filtering for noise removal). If not, the incorrect and unreliable values of the measured signals can result in wrong drug dosage delivered to the patient. Here, simulations are carried out by adding a disturbance pulse of strength 20 in the BIS signal (Struys et al. [2004] ) from t =5 0t o8 0min. 
CONCLUSION
This work illustrates the applicability of the novel RTDA controller for controlling hypnosis. The RTDA controller performs significantly better than the PID controller and does slightly better than the MPC controller in regulating hypnosis when tested on patient models. The RTDA controller also appears to be robust in the context of variation in patient parameters.
